Menu
GWAS Study

Genetic determinants of circulating GIP and GLP-1 concentrations.

Almgren P, Lindqvist A, Krus U et al.

29093273 PubMed ID
GWAS Study Type
8249 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AP
Almgren P
LA
Lindqvist A
KU
Krus U
HL
Hakaste L
OE
Ottosson-Laakso E
AO
Asplund O
SE
Sonestedt E
PR
Prasad RB
LE
Laurila E
OM
Orho-Melander M
MO
Melander O
TT
Tuomi T
HJ
Holst JJ
NP
Nilsson PM
WN
Wierup N
GL
Groop L
AE
Ahlqvist E
Chapter II

Abstract

Summary of the research findings

The secretion of insulin and glucagon from the pancreas and the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) from the gastrointestinal tract is essential for glucose homeostasis. Several novel treatment strategies for type 2 diabetes (T2D) mimic GLP-1 actions or inhibit incretin degradation (DPP4 inhibitors), but none is thus far aimed at increasing the secretion of endogenous incretins. In order to identify new potential therapeutic targets for treatment of T2D, we performed a meta-analysis of a GWAS and an exome-wide association study of circulating insulin, glucagon, GIP, and GLP-1 concentrations measured during an oral glucose tolerance test in up to 7,828 individuals. We identified 6 genome-wide significant functional loci associated with plasma incretin concentrations in or near the SLC5A1 (encoding SGLT1), GIPR, ABO, GLP2R, F13A1, and HOXD1 genes and studied the effect of these variants on mRNA expression in pancreatic islet and on metabolic phenotypes. Immunohistochemistry showed expression of GIPR, ABO, and HOXD1 in human enteroendocrine cells and expression of ABO in pancreatic islets, supporting a role in hormone secretion. This study thus provides candidate genes and insight into mechanisms by which secretion and breakdown of GIP and GLP-1 are regulated.

3,344 Swedish ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

8249
Total Participants
GWAS
Study Type
Yes
Replicated
4,905 Finnish ancestry individuals
Replication Participants
European
Ancestry
Sweden, Finland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.